Board to consider Final Dividend
Caplin Point Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 25, 2014:1. To consider and approve inter-alia Audited Financial Results of the Company for the fourth quarter and year ended June 30, 2014.2. To consider recommendation of Final Dividend for the FY 2013-14, if any. Shareholding Pattern For June 30, 2014
Caplin Point Laboratories Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014. Commencement of Additional Line of Production
Caplin Point Laboratories Ltd has informed BSE that the Companys Plant at Pondicherry, has commenced its additional line of Production in the area of Suppositories which is unique in its feature which very few Pharma Companies have. This will now enable export of these products to Semi regulated and non regulated markets which includes Dominican Republic, Guatemala, Nicaragua, El Salvador, Honduras, in Latin American Countries & Angola, Mali in West African countries. Outcome of Board Meeting (Re-designation of Chief Financial Officer & Company Secretary)
Caplin Point Laboratories Ltd has informed BSE that the Board has re-designated Mr. S. Mohanraj as the Chief Financial Officer & Company Secretary at its meeting held on May 12, 2014. Terms & Conditions of Appointment of Independent Director
With reference to the earlier announcement regarding appointment of Mr. R. Ravichandran as an Additional Director (Non-Executive Independent Director) of the Company at the meeting of the Board of Directors of the Company held on May 12, 2014, Caplin Point Laboratories Ltd has now informed BSE that the terms & conditions of appointment of Mr. R. Ravichandran is attached along with his profile as per the provisions of the SEBI circular dated April 17, 2014. Outcome of Board Meeting
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2014, have appointed Mr. R. Ravichandran as an Additional Director of the Company. Financial Results & Limited Review for March 31, 2014
Caplin Point Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended March 31, 2014. Shareholding Pattern For March 31, 2014
Caplin Point Laboratories Ltd has informed BSE about the Shareholding Pattern as on March 31, 2014. Re-appointment of Managing Director
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company have re-appointed Mr. M. Jayapal as Managing Director of the Company for a further period of one year with effect from March 28, 2014.The Board also fixed the revised remuneration payable to him. The term and remuneration payable to Mr. M. Jayapal is subject to the approval of the Shareholders at the ensuing General Meeting. Commencement of Commercial Production
Caplin Point Laboratories Ltd has informed BSE that the Companys state of art injectable Plant near Gummidipoondi, Tamil Nadu to cater regulated markets USA, EU, Brazil, South Africa etc., has commenced its commercial Production on March 27, 2014. This will now enable export of these products to Semi regulated and non regulated markets.The Company has now initiated the process of submitting required documents for obtaining approval from...